1. Home
  2. GSK vs EQIX Comparison

GSK vs EQIX Comparison

Compare GSK & EQIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSK
  • EQIX
  • Stock Information
  • Founded
  • GSK 1715
  • EQIX 1998
  • Country
  • GSK United Kingdom
  • EQIX United States
  • Employees
  • GSK N/A
  • EQIX N/A
  • Industry
  • GSK Biotechnology: Pharmaceutical Preparations
  • EQIX Real Estate Investment Trusts
  • Sector
  • GSK Health Care
  • EQIX Real Estate
  • Exchange
  • GSK Nasdaq
  • EQIX Nasdaq
  • Market Cap
  • GSK 71.7B
  • EQIX 82.2B
  • IPO Year
  • GSK N/A
  • EQIX 2000
  • Fundamental
  • Price
  • GSK $36.64
  • EQIX $864.39
  • Analyst Decision
  • GSK Hold
  • EQIX Strong Buy
  • Analyst Count
  • GSK 4
  • EQIX 18
  • Target Price
  • GSK $47.00
  • EQIX $1,007.94
  • AVG Volume (30 Days)
  • GSK 5.4M
  • EQIX 510.3K
  • Earning Date
  • GSK 04-30-2025
  • EQIX 04-30-2025
  • Dividend Yield
  • GSK 4.36%
  • EQIX 2.17%
  • EPS Growth
  • GSK N/A
  • EQIX N/A
  • EPS
  • GSK 0.98
  • EQIX 9.59
  • Revenue
  • GSK $40,735,668,430.00
  • EQIX $8,814,000,000.00
  • Revenue This Year
  • GSK $7.19
  • EQIX $6.50
  • Revenue Next Year
  • GSK $5.34
  • EQIX $8.33
  • P/E Ratio
  • GSK $18.28
  • EQIX $90.17
  • Revenue Growth
  • GSK 2.57
  • EQIX 5.82
  • 52 Week Low
  • GSK $31.72
  • EQIX $701.41
  • 52 Week High
  • GSK $45.93
  • EQIX $994.03
  • Technical
  • Relative Strength Index (RSI)
  • GSK 44.68
  • EQIX 58.62
  • Support Level
  • GSK $36.42
  • EQIX $839.57
  • Resistance Level
  • GSK $39.23
  • EQIX $882.88
  • Average True Range (ATR)
  • GSK 0.76
  • EQIX 19.11
  • MACD
  • GSK -0.07
  • EQIX 5.89
  • Stochastic Oscillator
  • GSK 13.02
  • EQIX 77.71

About GSK GSK plc (Each representing two)

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

About EQIX Equinix Inc. REIT

Equinix operates 260 data centers in 71 markets worldwide. It generates 44% of total revenue in the Americas, 35% in Europe, the Middle East, and Africa, and 21% in Asia-Pacific. The firm has more than 10,000 customers, including 2,100 network providers, that are dispersed over five verticals: cloud and IT services, content providers, network and mobile services, financial services, and enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from interconnection. Equinix operates as a real estate investment trust.

Share on Social Networks: